Latest

mTOR

This shows a person's finger zapping a brain with electricity

·March 12, 2022·4 min read

Brain Cell Insight Could Lead to New Treatments for Neurological-Based Diseases

Study reports oligodendrocytes in the brain are distinct from oligodendrocytes in the central nervous system due to their metabolic processes. The findings may shed new light on neurological and autoimmune dysfunction in multiple sclerosis and other neurodegenerative disorders.

Featured Neuroscience Psychology

·April 1, 2021·6 min read

Disrupted Biochemical Pathway in the Brain Linked to Bipolar Disorder

Disruptions in the Atk protein can lead to brain changes that are characteristic of bipolar disorder.

Autism Featured Genetics Neuroscience

·March 2, 2020·4 min read

Could targeting an Alzheimer’s-associated protein prevent Autism?

Reducing levels of the Alzheimer's related Tau protein prevents autism-like behaviors in mouse models. Tau reduction also prevented seizures in the animals.

Autism Featured Genetics Neuroscience

·October 21, 2019·4 min read

New therapeutic strategy may help reverse autism behavioral abnormalities

Genetically silencing mTORC2 in mouse models prolonged lifespan, suppressed seizures, increased long-term memory, and reduced autism-like behaviors.

Featured Genetics Neuroscience

·August 26, 2019·3 min read

Scientists have found longevity biomarkers

Exploring the effects of 17 different lifespan-extending interventions on gene activity, researchers identified genetic biomarkers for longevity in mice.

Featured Neuroscience Psychology

·July 31, 2019·4 min read

Ketamine isn’t an opioid and treats depression in a unique way

A new study clarifies the mechanism behind how ketamine works as an antidepressant. Researchers say there is evidence to suggest ketamine binds to NMDA receptors, instead of opioid receptors. Reducing the belief that ketamine is an opioid may make patients with depression more open to using the treatment.

Featured Genetics Neuroscience Open Neuroscience Articles

·May 23, 2019·3 min read

A new pathway for an anti-aging drug

TRPML1 may contribute to the neuroprotective and anti-aging properties of rapamycin.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·April 10, 2019·4 min read

Protein pileup affects social behaviors through altered brain signaling

Study implicates disrupted autophagy and protein aggregation in the pathogenesis of autism schizophrenia and social behavior deficits in other disorders.

this diagram shows how the drug combinations lead to apoptosis in brain cancer

Brain Cancer Featured Neurology Neuroscience

·March 22, 2019·4 min read

New drug combination shows promise for common pediatric brain tumor

Combining carboplatin, a common chemotherapy drug, with everolimus, a drug that blocks mTOR, is effective at inducing apoptosis and slowing tumor growth in patients with pediatric low-grade glioma brain cancer.

Featured Neuroscience Open Neuroscience Articles

·November 15, 2018·4 min read

Seeing and Smelling Food Prepares the Liver for Digestion: Mouse Study

Researchers say the sight and smell of food alone may be enough to prompt the liver to start the processes that help digest food.

Featured Neuroscience Open Neuroscience Articles Psychology

·October 3, 2018·5 min read

Connection Between Cognitive Function and Diet

A new study reports the Ketogenic diet can help to improve cognition. The study reports the Ketogenic diet can help improve balance in the gut microbiome, lower blood glucose levels and increase the processes that help to clear amyloid beta from the brain.

image shows neurons under psychedelics and ketamine

Featured Neuroscience Open Neuroscience Articles Psychology

·June 12, 2018·4 min read

Ketamine and Psychedelic Drugs Change Structure of Neurons

A new study reveals psychedelics increase dendrites, dendritic spines and synapses, while ketamine may promote neuroplasticity. The findings could help develop new treatments for anxiety, depression and other related disorders.

1 2 3 4